BPG is committed to discovery and dissemination of knowledge
Articles in Press
7/18/2025 8:12:09 AM | Browse: 10 | Download: 0
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 108672
Country China
Category Oncology
Manuscript Type Basic Study
Article Title DEAD/H-box RNA helicase 10 promotes pancreatic cancer cell proliferation via ribonucleotide reductase M2
Manuscript Source Unsolicited Manuscript
All Author List Zhi-Sheng Qiu, Xiao-Chun Wang, Ji-Chun Ma, Cheng-Lou Zhu, Yong-Li Hu and Ming-Xu Da
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China 82160588
Health Commission of Gansu Province GSWSKY2021-032
Natural Science Foundation of Gansu Province 24JRRA585
Gansu Provincial Hospital Science and Technology innovation platform fund project 21GSSYB-23
Corresponding Author Ming-Xu Da, Professor, The First Clinical Medical College, Lanzhou University, No. 222 Tianshui South Road, Chengguan District, Lanzhou 730000, Gansu Province, China. ldyy_damx@lzu.edu.cn
Key Words RRM2; DEAD-box RNA helicase 10; Pancreatic cancer proliferation; Migration; Invasion
Core Tip This study elucidates the role of DEAD-box RNA helicase 10 (DDX10) in pancreatic cancer (PC) progression. Through bioinformatics analysis, tissue microarray evaluation, and in vitro assays, we discovered that DDX10 is overexpressed in PC tissues compared to non-tumor tissues. Knockdown of DDX10 significantly inhibited cell proliferation, invasion, and migration while promoting apoptosis. Mechanistic investigations revealed that DDX10 regulates key oncogenes, including RRM2, which counteracts the growth-inhibitory effects of DDX10 knockdown. Importantly, DDX10 expression was found to negatively correlate with patient survival rates. These findings highlight DDX10 as a potential therapeutic target for PC.
Citation Qiu ZS, Wang XC, Ma JC, Zhu CL, Hu YL, Da MX. DEAD/H-box RNA helicase 10 promotes pancreatic cancer cell proliferation via ribonucleotide reductase M2. World J Gastrointest Oncol 2025; In press
Received
2025-04-21 05:15
Peer-Review Started
2025-04-21 05:16
To Make the First Decision
Return for Revision
2025-05-13 12:07
Revised
2025-05-23 08:58
Second Decision
2025-07-18 02:43
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-07-18 08:12
Articles in Press
2025-07-18 08:12
Publication Fee Transferred
2025-05-26 15:26
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com